3D Cell Culture Global Market - Forecast to 2024
Publishing Date : | February, 2018 |
Report Code : | HCBT0106 |
Price: |
Single license $4,950
Site license $6,750 Global license $9,000 |
3D cell culture is the method of creating an artificial environment that allows the cells to grow and interact within 3D structures. According to IQ4I analysis, the 3D cell culture global market is expected to grow at double digit CAGR to reach $1,485.1 million by 2024. Substantial R&D investments, use of 3D cell culture models in drug discovery and research as alternative to animal testing, emergence of microfluidic technology and bioprinting and increasing focus on regenerative medicine are some of the driving factors for this industry. However, lack of experienced and skilled professionals, budget restrictions for small and medium sized laboratories, lack of consistency in 3D cell culture products, stringent process controls for handling capabilities and ethical concerns over the use of animal sources are hindering the market to grow.
3D cell culture global market is classified based on technology, products, application, end-users, and geography. Based on technology the 3D cell culture market can be divided into two segments i.e., Scaffold based approaches and Scaffold free approaches. The scaffold based approaches are further classified into scaffolds, hydrogels and others. The scaffold free approaches are classified as the hang drop method, forced floating, agitation based methods, and microfludics. Based on products the segment is further classified as cells and tissues, media, sera and reagents, microplates and others, assay kits, scaffolds, and others (bioreactors and incubators). The application segment can be classified as basic research, toxicity and drug screening, tissue engineering, stem cell research, drug discovery, gene therapy and cancer research. The end-users segment can be classified as academic institutes, biotechnology and pharmaceutical industries and others.
Based on geography 3D cell culture global market is classified as North America, Europe, APAC and Rest of the world. North America accounts for the highest market share of 46.2% followed by Europe. However, Asian countries especially China and Japan are the fastest growing regions with its growing demand for 3D cell culture products.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Others
• Europe
o Germany
o U.K.
o France
o Others
• Asia-Pacific
o China
o Japan
o Korea
o Others
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle-East and Others
- 1 EXECUTIVE SUMMARY
- 2 INTRODUCTION
- 2.1 KEY TAKEAWAYS
- 2.2 REPORT DESCRIPTION
- 2.3 MARKETS COVERED
- 2.4 STAKEHOLDERS
- 2.5 RESEARCH METHODOLOGY
- 2.5.1 MARKET SIZE ESTIMATION
- 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.5.3 SECONDARY SOURCES
- 2.5.4 PRIMARY SOURCES
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
- 2.5.7 ASSUMPTIONS
- 3 MARKET ANALYSIS
- 3.1 INTRODUCTION
- 3.2 MARKET SEGMENTATION
- 3.3 FACTORS INFLUENCING MARKET
- 3.3.1 DRIVERS AND OPPORTUNITIES
- 3.3.1.1 SUBSTANTIAL R&D INVESTMENTS FOR 3D CELL CULTURE
- 3.3.1.2 USE OF 3D CELL CULTURE MODELS IN DRUG DISCOVERY AND RESEARCH AS AN ALTERNATIVE TO ANIMAL TESTING
- 3.3.1.3 EMERGENCE OF MICROFLUIDIC TECHNOLOGY AND BIOPRINTING
- 3.3.1.4 INCREASING FOCUS ON REGENERATIVE MEDICINE
- 3.3.2 RESTRAINTS AND THREATS
- 3.3.2.1 LACK OF EXPERIENCED AND SKILLED PROFESSIONALS
- 3.3.2.2 BUDGET RESTRICTION FOR SMALL AND MEDIUM SIZED LABORATORIES AND LACK OF CONSISTENCY IN 3D CELL CULTURE PRODUCTS
- 3.3.2.3 STRINGENT PROCESS CONTROLS FOR ADVANCED HANDLING CAPABILITIES
- 3.3.2.4 ETHICAL CONCERN OVER USE OF ANIMAL SOURCES
- 3.4 REGULATORY AFFAIRS
- 3.4.1 UNITED STATES
- 3.4.2 EUROPE
- 3.4.3 INDIA
- 3.4.4 JAPAN
- 3.5 TECHNOLOGICAL ADVANCEMENTS
- 3.5.1 INTRODUCTION
- 3.5.2 ORGAN-ON-CHIP
- 3.5.3 3D BIOPRINTING
- 3.5.4 SINGLE USE REACTORS
- 3.6 PORTER’S FIVE FORCE ANALYSIS
- 3.6.1 THREAT OF NEW ENTRANTS
- 3.6.2 THREAT OF SUBSTITUTES
- 3.6.3 BARGAINING POWER OF SUPPLIERS
- 3.6.4 BARGAINING POWER OF BUYERS
- 3.6.5 RIVALRY AMONG EXISTING COMPETITORS
- 3.7 SUPPLY CHAIN ANALYSIS
- 3.7.1 RAW MATERIAL SUPPLIER:
- 3.7.2 PRODUCT MANUFACTURERS:-
- 3.7.3 3D CELL CULTURE PRODUCTS DISTRIBUTORS
- 3.7.4 END-USERS
- 3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
- 4 3D CELL CULTURE GLOBAL MARKET, BY TECHNOLOGY
- 4.1 INTRODUCTION
- 4.2 SCAFFOLD BASED PLATFORMS
- 4.2.1 SCAFFOLDS
- 4.2.2 HYDROGELS
- 4.2.3 OTHERS
- 4.3 SCAFFOLD FREE PLATFORMS
- 4.3.1 HANG DROP METHOD
- 4.3.2 FORCED FLOATING
- 4.3.3 AGITATION BASED METHODS
- 4.3.4 MICROFLUIDICS
- 5 3D CELL CULTURE GLOBAL MARKET, BY PRODUCTS
- 5.1 INTRODUCTION
- 5.2 CELLS AND TISSUES
- 5.3 MEDIA, SERA AND REAGENTS
- 5.4 MICROPLATES AND OTHERS
- 5.5 ASSAY KITS
- 5.6 SCAFFOLDS
- 5.6.1 NATURAL SCAFFOLDS
- 5.6.2 SYNTHETIC SCAFFOLDS
- 5.6.3 HYBRID COMPOSITE
- 5.6.4 HYDROGELS
- 5.7 OTHERS
- 6 3D CELL CULTURE GLOBAL MARKET, BY APPLICATION
- 6.1 INTRODUCTION
- 6.2 BASIC RESEARCH
- 6.3 TOXICITY AND DRUG SAFETY SCREENING
- 6.4 TISSUE ENGINEERING
- 6.5 STEM CELL RESEARCH
- 6.6 DRUG DISCOVERY
- 6.7 CANCER RESEARCH
- 6.8 GENE THERAPY
- 7 3D CELL CULTURE GLOBAL MARKET, BY END-USERS
- 7.1 INTRODUCTION
- 7.2 ACADEMIC INSTITUTES
- 7.3 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
- 7.4 OTHERS
- 8 REGIONAL ANALYSIS
- 8.1 INTRODUCTION
- 8.2 NORTH AMERICA
- 8.2.1 U.S.
- 8.2.2 OTHERS
- 8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 U.K.
- 8.3.3 FRANCE
- 8.3.4 OTHERS
- 8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 JAPAN
- 8.4.3 KOREA
- 8.4.4 OTHERS
- 8.5 REST OF THE WORLD
- 8.5.1 BRAZIL
- 8.5.2 REST OF LATIN AMERICA
- 8.5.3 MIDDLE EAST AND OTHERS
- 9 COMPETITIVE LANDSCAPE
- 9.1 INTRODUCTION
- 9.2 COLLABORATIONS & PARTNERSHIPS
- 9.3 NEW PRODUCT LAUNCHES
- 9.4 AGREEMENTS, EXPANTIONS & MERGERS
- 9.5 COMPANY MATRIX
- 10 MAJOR COMPANIES
- 10.1 BECTON DICKINSON AND COMPANY
- 10.1.1 OVERVIEW
- 10.1.2 FINANCIALS
- 10.1.3 PRODUCT PORTFOLIO
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 BUSINESS STRATEGY
- 10.1.6 SWOT ANALYSIS
- 10.2 CORNING INCORPORATED
- 10.2.1 OVERVIEW
- 10.2.2 FINANCIALS
- 10.2.3 PRODUCT PORTFOLIO
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 BUSINESS STRATEGY
- 10.2.6 SWOT ANALYSIS
- 10.3 INSPHERO AG
- 10.3.1 OVERVIEW
- 10.3.2 FINANCIALS
- 10.3.3 PRODUCT PORTFOLIO
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 BUSINESS STRATEGY
- 10.3.6 SWOT ANALYSIS
- 10.4 JSR CORPORATION (ORGANOGENIX INC.)
- 10.4.1 OVERVIEW
- 10.4.2 FINANCIALS
- 10.4.3 PRODUCT PORTFOLIO
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 BUSINESS STRATEGY
- 10.4.6 SWOT ANALYSIS
- 10.5 KURARAY CO. LTD
- 10.5.1 OVERVIEW
- 10.5.2 FINANCIALS
- 10.5.3 PRODUCT PORTFOLIO
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 BUSINESS STRATEGY
- 10.5.6 SWOT ANALYSIS
- 10.6 LONZA GROUP
- 10.6.1 OVERVIEW
- 10.6.2 FINANCIALS
- 10.6.3 SERVICE PORTFOLIO
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 BUSINESS STRATEGY
- 10.6.6 SWOT ANALYSIS
- 10.7 MERCK KGAA
- 10.7.1 OVERVIEW
- 10.7.2 FINANCIALS
- 10.7.3 PRODUCT PORTFOLIO
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 BUSINESS STRATEGY
- 10.7.6 SWOT ANALYSIS
- 10.8 NANO 3D BIOSCIENCES, INC
- 10.8.1 OVERVIEW
- 10.8.2 FINANCIALS
- 10.8.3 PRODUCT PORTFOLIO
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 BUSINESS STRATEGY
- 10.8.6 SWOT ANALYSIS
- 10.9 ORGANOVO HOLDINGS INC.
- 10.9.1 OVERVIEW
- 10.9.2 FINANCIALS
- 10.9.3 PRODUCT PORTFOLIO
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 BUSINESS STRATEGY
- 10.9.6 SWOT ANALYSIS
- 10.10 THERMO FISHER SCIENTIFIC, INC
- 10.10.1 OVERVIEW
- 10.10.2 FINANCIALS
- 10.10.3 PRODUCT PORTFOLIO
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 BUSINESS STRATEGY
- 10.10.6 SWOT ANALYSIS
- TABLE 1 3D CELL CULTURE GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 2 3D CELL CULTURE GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2016-2024) ($MN)
- TABLE 3 SCAFFOLD BASED PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
- TABLE 4 SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 5 SCAFFOLDS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 6 HYDROGELS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 7 OTHERS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 8 SCAFFOLD FREE PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
- TABLE 9 SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 10 HANGDROP METHOD MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 11 FORCED FLOATING MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 12 AGITATION BASED METHODS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 13 MICROFLUIDICS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 14 3D CELL CULTURE GLOBAL MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
- TABLE 15 CELLS & TISSUES MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 16 MEDIA, SERA & REAGENTS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 17 MICROPLATES & OTHERS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 18 ASSAY KITS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 19 SCAFFOLDS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 20 SCAFFOLDS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
- TABLE 21 NATURAL SCAFFOLDS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 22 SYNTHETIC SCAFFOLDS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 23 HYBRID COMPOSITE MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 24 HYDROGELS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 25 OTHERS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 26 3D CELL CULTURE GLOBAL MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 27 BASIC REASEARCH MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 28 TOXICITY AND DRUG SAFETY SCREENING MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 29 TISSUE ENGINEERING MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 30 STEM CELL RESEARCH MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 31 DRUG DISCOVERY MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 32 CANCER RESEARCH MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 33 GENE THERAPY MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 34 3D CELL CULTURE GLOBAL MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 35 ACADEMIC INSTITUTES MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 36 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 37 OTHERS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
- TABLE 38 3D CELL CULTURE GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 39 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
- TABLE 40 NORTH AMERICA SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
- TABLE 41 NORTH AMERICA SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
- TABLE 42 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
- TABLE 43 NORTH AMERICA SCAFFOLDS MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
- TABLE 44 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 45 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 46 EUROPE 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
- TABLE 47 EUROPE SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
- TABLE 48 EUROPE SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
- TABLE 49 EUROPE 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
- TABLE 50 EUROPE SCAFFOLDS MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
- TABLE 51 EUROPE 3D CELL CULTURE MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 52 EUROPE 3D CELL CULTURE MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 53 APAC 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
- TABLE 54 APAC SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
- TABLE 55 APAC SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
- TABLE 56 APAC 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
- TABLE 57 APAC SCAFFOLDS MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
- TABLE 58 APAC 3D CELL CULTURE MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 59 APAC 3D CELL CULTURE MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 60 ROW 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
- TABLE 61 ROW SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
- TABLE 62 ROW SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
- TABLE 63 ROW 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
- TABLE 64 ROW SCAFFOLDS MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
- TABLE 65 ROW 3D CELL CULTURE MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 66 ROW 3D CELL CULTURE MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 67 COLLABORATIONS & PARTNERSHIPS (JAN 2016 – JAN 2018)
- TABLE 68 NEW PRODUCT LAUNCH(JAN 2016 – JAN 2018)
- TABLE 69 AGREEMENTS, EXPANTIONS & MERGERS (JAN 2016 – JAN 2018)
- TABLE 70 COMPANY MATRIX: COMPANY V/S PRODUCT OFFERING
- TABLE 71 BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 72 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 73 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 74 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 75 CORNING INCORPORATED: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
- TABLE 76 CORNING INCORPORATED: TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN)
- TABLE 77 CORNING INCORPORATED: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
- TABLE 78 KURARAY CO. LTD: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
- TABLE 79 KURARAY CO. LTD. : TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN)
- TABLE 80 KURARAY CO. LTD: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
- TABLE 81 LONZA GROUP: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
- TABLE 82 LONZA GROUP: TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN)
- TABLE 83 LONZA GROUP: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
- TABLE 84 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 85 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 86 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 87 ORGANOVO HOLDINGS INC.: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
- TABLE 88 THERMO FISHER SCIENTIFIC, INC: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
- TABLE 89 THERMO FISHER SCIENTIFIC, INC : TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN)
- TABLE 90 THERMO FISHER SCIENTIFIC, INC: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
- FIGURE 1 GLOBAL 3D CELL CULTURE MARKET SHARE AND REVENUE, BY REGION, (2016-2024) ($MN)
- FIGURE 2 RESEARCH METHODOLOGY: 3D CELL CULTURE GLOBAL MARKET
- FIGURE 3 3D CELL CULTURE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
- FIGURE 4 3D CELL CULTURE GLOBAL MARKET: FORECASTING MODEL
- FIGURE 5 3D CELL CULTURE: MARKET BREAKDOWN & DATA TRIANGULATION
- FIGURE 6 3D CELL CULTURE GLOBAL MARKET: MARKET SEGMENTATION
- FIGURE 8 3D CELL CULTURE MARKET: PORTER’S ANALYSIS
- FIGURE 9 3D CELL CULTURE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 10 3D CELL CULTURE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017
- FIGURE 11 3D CELL CULTURE GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2017-2024) ($MN)
- FIGURE 12 3D CELL CULTURE SCAFFOLD BASED PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2017) ($MN)
- FIGURE 13 3D CELL CULTURE SCAFFOLD FREE PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2017) ($MN)
- FIGURE 14 SCAFFOLD BASED PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
- FIGURE 15 SCAFFOLD FREE PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
- FIGURE 16 3D CELL CULTURE GLOBAL MARKET REVENUE, BY PRODUCT, (2017 V/S 2024) ($MN)
- FIGURE 17 SCAFFOLDS GLOBAL MARKET REVENUE, BY TYPE, (2017 V/S 2024) ($MN)
- FIGURE 18 3D CELL CULTURE GLOBAL MARKET REVENUE, BY APPLICATION, (2017 V/S 2024) ($MN)
- FIGURE 19 3D CELL CULTURE GLOBAL MARKET SHARE, BY APPLICATION, (2017) (%) CAGR (%)
- FIGURE 20 3D CELL CULTURE GLOBAL MARKET REVENUE, BY END-USERS, (2017 V/S 2024) ($MN)
- FIGURE 21 3D CELL CULTURE GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
- FIGURE 22 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2017 VS 2024) ($MN)
- FIGURE 23 NORTH AMERICA SCAFFOLD BASED PLATFORMS & SCAFFOLD FREE PLATFORM MARKET, BY TYPE (2017 VS 2024) ($MN)
- FIGURE 24 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 25 NORTH AMERICA SCAFFOLDS MARKET REVENUE, BY TYPE (2017 VS 2024) ($MN)
- FIGURE 26 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
- FIGURE 27 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY END-USERS (2017 VS 2024) ($MN)
- FIGURE 28 U.S. 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 29 U.S. 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 30 OTHER NORTH AMERICAN COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 31 OTHER NORTH AMERICAN COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 32 EUROPE 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2017 VS 2024) ($MN)
- FIGURE 33 EUROPE SCAFFOLD BASED PLATFORMS & SCAFFOLD FREE PLATFORM MARKET, BY TYPE (2017 VS 2024) ($MN)
- FIGURE 34 EUROPE 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 35 EUROPE SCAFFOLDS MARKET REVENUE, BY TYPE (2017 VS 2024) ($MN)
- FIGURE 36 EUROPE 3D CELL CULTURE MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
- FIGURE 37 EUROPE 3D CELL CULTURE MARKET REVENUE, BY END-USERS (2017 VS 2024) ($MN)
- FIGURE 38 GERMANY 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 39 GERMANY 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 40 U.K. 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 41 U.K. 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 42 FRANCE 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 43 FRANCE 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 44 OTHER EUROPEAN COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 45 OTHER EUROPEAN COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 46 APAC 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2017 VS 2024) ($MN)
- FIGURE 47 APAC SCAFFOLD BASED PLATFORMS & SCAFFOLD FREE PLATFORM MARKET, BY TYPE (2017 VS 2024) ($MN)
- FIGURE 48 APAC 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 49 APAC SCAFFOLDS MARKET REVENUE, BY TYPE (2017 VS 2024) ($MN)
- FIGURE 50 APAC 3D CELL CULTURE MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
- FIGURE 51 APAC 3D CELL CULTURE MARKET REVENUE, BY END-USERS (2017 VS 2024) ($MN)
- FIGURE 52 CHINA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 53 CHINA 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 54 JAPAN 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 55 JAPAN 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 56 KOREA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 57 KOREA 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 58 OTHER APAC COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 59 OTHER APAC COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 60 ROW 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2017 VS 2024) ($MN)
- FIGURE 61 ROW SCAFFOLD BASED PLATFORMS & SCAFFOLD FREE PLATFORM MARKET, BY TYPE (2017 VS 2024) ($MN)
- FIGURE 62 ROW 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 63 ROW SCAFFOLDS MARKET REVENUE, BY TYPE (2017 VS 2024) ($MN)
- FIGURE 64 ROW 3D CELL CULTURE MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
- FIGURE 65 ROW 3D CELL CULTURE MARKET REVENUE, BY END-USERS (2017 VS 2024) ($MN)
- FIGURE 66 BRAZIL 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 67 BRAZIL 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 68 REST OF LATIN AMERICA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 69 REST OF LATIN AMERICA 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 70 MIDDLE EAST AND OTHERS 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
- FIGURE 71 MIDDLE EAST AND OTHERS 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
- FIGURE 72 KEY GROWTH STRATEGIES, (JAN 2016 – JAN 2018)
- FIGURE 73 OVERVIEW: BECTON DICKINSON AND COMPANY
- FIGURE 74 SWOT: BECTON DICKINSON AND COMPANY
- FIGURE 75 OVERVIEW: CORNING INCORPORATED
- FIGURE 76 SWOT: CORNING INCORPORATED
- FIGURE 77 SWOT: INSPHERO AG
- FIGURE 78 SWOT: ORGANOGENIX INC.
- FIGURE 79 OVERVIEW: KURARAY CO. LTD
- FIGURE 80 SWOT: KURARAY CO. LTD
- FIGURE 81 OVERVIEW: LONZA GROUP
- FIGURE 82 SWOT: LONZA GROUP
- FIGURE 83 OVERVIEW: MERCK KGAA
- FIGURE 84 SWOT: MERCK KGAA
- FIGURE 85 SWOT: NANO 3D BIOSCIENCES
- FIGURE 86 OVERVIEW: ORGANOVO HOLDINGS INC.
- FIGURE 87 SWOT: ORGANOVO HOLDINGS INC
- FIGURE 88 OVERVIEW: THERMO FISHER SCIENTIFIC INC
- FIGURE 89 SWOT: THERMO FISHER SCIENTIFIC, INC
- 1 300 MICRONS GMBH
- 2 3D BIOTEK, LLC
- 3 3D MATRIX CO.
- 4 3DTRO AB
- 5 ADVANCED BIOMATRIX, INC.
- 6 AIM BIOTECH PTE LTD.
- 7 AKRON BIOTECHNOLOGY, LLC
- 8 AMSBIO LLC
- 9 ASCENDANCE
- 10 ASPECT BIOSYSTEMS
- 11 ASTERAND BIOSCIENCE
- 12 AVANTICELL SCIENCE
- 13 BASF
- 14 BECTON, DICKINSON AND COMPANY
- 15 BELLBROOKS LABS
- 16 BELLCO GLASS, INC
- 17 BIOCELLCHALLENGE
- 18 BIOGELX LTD.
- 19 BIOLAMINA AB
- 20 BIOMERIX
- 21 BIOVISION, INC.
- 22 BIOZOL GMBH
- 23 BISS TGT
- 24 BRTI LIFE SCIENCES
- 25 CELARTIA
- 26 CELL APPLICATIONS, INC.
- 27 CELL BIO LABS
- 28 CELL SPRING
- 29 CELLECBIOTEK AG
- 30 CELLENDES GMBH
- 31 CELLEVATE AB
- 32 CELLINK
- 33 CELLNTEC ADVANCED CELL SYSTEMS AG
- 34 CELPROGEN
- 35 CELVIVO IVS
- 36 CHARLES RIVER LABORATORIES
- 37 CNBIO INNOVATIONS LTD.
- 38 CORNING INC.
- 39 CTIBIOTECH
- 40 CYFUSE BIOMEDICAL KK
- 41 CYTOO
- 42 DIA GENODE
- 43 DWK LIFE SCIENCES
- 44 EBERS MEDICAL TECHNOLOGY SL
- 45 ECTICA TECHNOLOGIES AG
- 46 ELECTROSPINNING COMPANY
- 47 EMULATE, INC.
- 48 ESI BIO
- 49 FIBERCELL SYSTEMS INC.
- 50 FLUIDINOVA SA
- 51 FUJIFILM
- 52 GENLANTIS (GENE THERAPY SYSTEMS, INC.)
- 53 GLOBAL CELL SOLUTIONS, INC
- 54 GRADIENTECH AB
- 55 GREINER BIO-ONE GMBH
- 56 GUANGZHOU JET BIO-FILTRATION CO., LTD.
- 57 KERANETICS
- 58 HOKKAIDO SODA
- 59 HUREL CORP
- 60 IBIDI GMBH
- 61 INSPHERO
- 62 INVIVO SCIENCES
- 63 IRVINE SCIENTIFIC
- 64 IV TECH SRL
- 65 JAPAN VILENE COMPANY
- 66 JSR CORPORATION (ORGANOGENIX INC.)
- 67 KIRKSTALL LTD
- 68 KOKEN CO. LTD.
- 69 KOLLOIDIS BIOSCIENCES
- 70 KURARAY CO., LTD.
- 71 LENA BIOSCIENCES, INC.
- 72 LIFECORE BIOMEDICAL,
- 73 LOCATE THERAPEUTICS
- 74 LONZA GROUP
- 75 MATRICEL GMBH
- 76 MATTEK CORPORATION
- 77 MENICON LIFE SCIENCE
- 78 MERCK KGAA
- 79 MICROTISSUES, INC.
- 80 MILTENYI BIOTEC GMBH
- 81 MIMETAS B.V.
- 82 MIRUS BIO
- 83 NANO 3D BIOSCIENCES INC
- 84 NANOFIBER SOLUTIONS
- 85 NANOLIVE SA
- 86 NANOPHARMA A.S.
- 87 NEUROMICS INC
- 88 ORGANOVO HOLDINGS, INC
- 89 PEPGEL LLC
- 90 PERKINELMER
- 91 PISHON BIOMEDICAL
- 92 PRODIZEN
- 93 PROMEGA CORPORATION
- 94 PROMOCELL GMBH
- 95 PROTISTA INTERNATIONAL AB
- 96 QGEL BIO
- 97 QUORUS BIOTECH (PTY) LTD.
- 98 REALBIO TECHNOLOGY INC.
- 99 REGENOVO
- 100 REPROCELL (REINNERVATE LTD. )
- 101 SANGI CO., LTD.
- 102 SARTORIUS STEDIM BIOTECH
- 103 STEMCELL TECHNOLOGIES INC.
- 104 STEMTEK
- 105 SUMITOMO BAKELITE CO. LTD.
- 106 SYNTHECON, INC
- 107 SYNVIVO LLC
- 108 TAKARA BIO INC (CLONTECH)
- 109 TETEC AG (B BRAUN)
- 110 THE WELL BIOSCIENCE INC.
- 111 THERMO FISHER SCIENTIFIC
- 112 TREVIGEN, INC.
- 113 UPM
- 114 VORNIA BIOMATERIALS LTD.
- 115 XANOFI
- 116 ZPREDICTA, INC.